🏅 FDA Orphan Designation

DaunoXome

Daunorubicin citrate liposome injection

Manufacturer: NeXstar Pharmaceuticals, Inc.

Indicated for:

OBSOLETE: HIV-related Kaposi sarcomaOrphan

FDA-Approved Indications (1)

OBSOLETE: HIV-related Kaposi sarcomaOrphan Designation

First line cytotoxic therapy for advanced, HIV related Kaposi's sarcoma.

Indications & Usage

First line cytotoxic therapy for advanced, HIV related Kaposi's sarcoma.

💙 Support Programs

View all →

DaunoXome

NeXstar Pharmaceuticals, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.